Volume 4, Issue 7 | July 2026
|
|
|
|
|
|
|
|
|
|
|
Discover licensing and collaboration opportunities
|
|
|
|
Explore a curated innovation portfolio featuring Mayo Clinic–originated companies and partner-ready technologies available for licensing or collaboration, spanning multiple modalities and disease areas.
|
|
|
|
|
|
Top Mayo Clinic headlines
|
|
|
|
|
|
|
Mayo Clinic strengthens innovation ecosystem to advance discoveries from ideas to patient impact
Mayo Clinic News Network
Mayo Clinic's Berg Innovation Exchange and Business Development have joined forces to better connect researchers, entrepreneurs and industry partners, accelerating commercialization, venture creation and the translation of promising discoveries into patient care. Read more...
|
|
|
|
|
|
|
Rearchitecting healthcare data for more cures
Bold. Forward. Leadership
Gianrico Farrugia, M.D., president and CEO of Mayo Clinic, outlines why modern healthcare data infrastructure is essential for AI-driven discovery, highlighting how Mayo Clinic Platform is accelerating research, clinical trials and collaboration to bring more cures to patients. Read more...
|
|
|
|
|
|
Portfolio company and collaboration updates
|
|
|
|
|
|
|
|
Cognivia announced a collaboration to advance behavioral intelligence across clinical research and clinical care.
|
|
|
|
|
|
Syntax Bio announced an expanded Series A financing and leadership appointments to support pipeline development.
|
|
|
|
|
|
Adze Biotechnology dosed the first patient in its Phase 1 trial evaluating ADZE1.C for advanced melanoma.
|
|
|
|
|
|
Hurone AI announced a collaboration to integrate social determinants of health into AI-powered cancer navigation.
|
|
|
|
|
|
Star51 Capital announced the first close of its medtech venture fund to support investments in emerging medtech.
|
|
|
|
|
|
Kardigan filed for an IPO to support advancement of its cardiovascular pipeline.
|
|
|
|
|
|
Syntax Bio announced a collaboration to advance pancreatic cell therapy for type 1 diabetes.
|
|
|
|
|
|
Nucleus RadioPharma announced a strategic alliance with Thermo Fisher Scientific to advance radiopharmaceutical development.
|
|
|
|
|
|
Cellxlife licensed a clinical-stage ovarian cancer vaccine candidate to expand its oncology pipeline.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COLLABORATOR SNAPSHOT
QlarisBio
A clinical-stage biotechnology company developing first-in-class therapies for glaucoma and other ophthalmic diseases.
WHY IT MATTERS
QLS-111 is designed to be the first glaucoma therapy to lower intraocular pressure by targeting episcleral venous pressure - a novel mechanism that addresses a key unmet need.
BUSINESS DEVELOPMENT CONNECTION
Mayo Clinic licensed the foundational technology behind QLS-111 to Qlaris Bio, advancing a promising ophthalmology innovation toward commercialization and patient impact.
|
|
|
The latest Mayo Clinic research
|
|
|
|
Inside new efforts at Mayo Clinic to decode and repair the brain using data
Mayo Clinic News Network
Mayo Clinic's BIONIC initiative aims to decode the brain's electrical signals by combining AI, bioengineering and neuroscience to develop personalized diagnostics and therapies for neurological diseases. Led by Dr. Gelareh Zadeh, the multidisciplinary effort seeks to integrate large-scale brain data, advance neuromodulation technologies and accelerate new treatments for conditions including epilepsy, stroke, Parkinson's disease and brain tumors.
Learn more...
|
|
|
|
|
Common drug may help prevent liver failure after surgery
|
|
|
|
Key protein linked to cancer and neurological diseases mapped
|
|
|
|
Immune pathway linked to cancer response newly identified
|
|
|
|
|
|
|
New kidney pathway may improve polycystic kidney disease treatment
|
|
|
|
New transplant protocol eliminated heavy alcohol relapse
|
|
|
|
Hidden biology of common brain tumors mapped
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cardiology & Radiology Innovation Summit brings innovators together
Last month, Mayo Clinic’s Cardiology & Radiology Innovation Summit convened leading clinicians, industry executives, investors and startup innovators to explore emerging technologies, foster new collaborations and advance ideas to improve patient care. The event featured discussions on topics ranging from next-generation surgical robotics to heart failure innovation, alongside networking and pitching opportunities. See more...
|
|
|
|
Business Development is pleased to welcome Heather Rose, PhD, JD, as Executive Director and Business Development lead for Mayo Clinic in Arizona.
Heather brings more than a decade of experience in commercialization, technology transfer and venture creation across therapeutics, diagnostics, medical devices and digital health. Most recently, she led technology licensing and venture creation at Thomas Jefferson University, where she oversaw commercialization strategy, startup formation and strategic collaborations across a diverse innovation portfolio.
Heather looks forward to connecting with industry, startup and investor communities to explore opportunities for collaboration and innovation. Get connected...
|
|
|
|
|
|
|
|
Located at Discovery Square in the heart of the Rochester, MN medical district, the unique facility will feature state-of-the-art laboratories and fully furnished office spaces in a thoughtfully designed, co-working facility that promotes collaboration, community and the success of innovative startups. Learn more...
|
|
|
|
|
|
|
|
|
|
|
About Business Development
|
Business Development is Mayo Clinic’s front door to business – from technology commercialization to strategic collaborations – catalyzing innovation to shape the future of healthcare for the benefit of patients.
The department bridges the gaps between industry and commercial groups to produce meaningful, effective changes in transforming health and medicine.
|
|
|
|
|
|
|
|
|
